Dorsey & Whitney Trust CO LLC Sells 82 Shares of The Cigna Group (NYSE:CI)

Dorsey & Whitney Trust CO LLC decreased its holdings in shares of The Cigna Group (NYSE:CI) by 3.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,016 shares of the health services provider’s stock after selling 82 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in The Cigna Group were worth $666,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of CI. Silicon Valley Capital Partners grew its stake in The Cigna Group by 100.0% in the first quarter. Silicon Valley Capital Partners now owns 70 shares of the health services provider’s stock worth $25,000 after purchasing an additional 35 shares in the last quarter. Cedar Wealth Management LLC purchased a new stake in shares of The Cigna Group in the 1st quarter worth $29,000. Raleigh Capital Management Inc. grew its position in shares of The Cigna Group by 69.5% during the 4th quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock worth $30,000 after buying an additional 41 shares in the last quarter. TruNorth Capital Management LLC purchased a new position in shares of The Cigna Group during the second quarter valued at $33,000. Finally, Pineridge Advisors LLC bought a new stake in shares of The Cigna Group in the fourth quarter valued at about $37,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on CI. Baird R W raised shares of The Cigna Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a report on Tuesday. Royal Bank of Canada reissued an “outperform” rating and issued a $384.00 price objective on shares of The Cigna Group in a research note on Monday. JPMorgan Chase & Co. lifted their price target on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. Finally, StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. One research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, The Cigna Group currently has a consensus rating of “Buy” and an average price target of $387.00.

The Cigna Group Trading Down 0.2 %

Shares of NYSE:CI opened at $357.44 on Thursday. The business’s 50 day moving average price is $342.53 and its 200-day moving average price is $343.92. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $370.64. The firm has a market capitalization of $99.92 billion, a price-to-earnings ratio of 29.35, a price-to-earnings-growth ratio of 1.08 and a beta of 0.50. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.71 and a quick ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 earnings per share for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The company had revenue of $60.52 billion during the quarter, compared to analysts’ expectations of $58.30 billion. During the same period in the prior year, the business posted $6.13 earnings per share. The firm’s revenue for the quarter was up 24.6% on a year-over-year basis. On average, equities research analysts forecast that The Cigna Group will post 28.48 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th will be paid a dividend of $1.40 per share. The ex-dividend date is Wednesday, September 4th. This represents a $5.60 annualized dividend and a yield of 1.57%. The Cigna Group’s dividend payout ratio (DPR) is currently 45.98%.

Insider Buying and Selling at The Cigna Group

In other news, Director Elder Granger sold 547 shares of The Cigna Group stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the sale, the director now directly owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elder Granger sold 547 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the transaction, the director now owns 5,471 shares in the company, valued at $1,812,979.98. The disclosure for this sale can be found here. Insiders sold 8,033 shares of company stock valued at $2,757,740 over the last quarter. 0.60% of the stock is currently owned by insiders.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.